Walleye Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $87.2K | Buy |
+288
| New | +$87.2K | ﹤0.01% | 1552 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2148 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2418 |
|
|
2024
Q3 | – | Sell |
-58
| Closed | -$16.2K | – | 2714 |
|
|
2024
Q2 | $16.2K | Sell |
58
-1,035
| -95% | -$290K | ﹤0.01% | 2304 |
|
|
2024
Q1 | $292K | Buy |
+1,093
| New | +$292K | ﹤0.01% | 1654 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2539 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2490 |
|
|
2020
Q1 | – | Sell |
-307
| Closed | -$28K | – | 779 |
|
|
2019
Q4 | $28K | Buy |
+307
| New | +$28K | ﹤0.01% | 555 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 790 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 733 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 507 |
|